The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) on Tuesday, May 7, released its 2018 Annual Report, which outlines some of the society’s key milestones.
According to a press release, ISPOR posted record attendance at its 2018 meeting in Europe with more than 5,500 attendees, while its journal, Value in Health, reached an impact factor of 5.494.
“Since its inception in 1995, ISPOR has continued to expand its reach and its influence in establishing international good research practices for the conduct and application of health economics and outcomes research (HEOR) around the world,” ISPOR CEO Nancy Berg said. “In 2018, ISPOR set new records, launched many new initiatives, and reinvested heavily in our mission.”
To read the full press release, click here.